Goldman Sachs’s Sana Biotechnology SANA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.16M Buy
3,181,115
+1,692,738
+114% +$6.67M ﹤0.01% 3141
2025
Q4
$6.06M Buy
1,488,377
+806,285
+118% +$3.61M ﹤0.01% 3571
2025
Q3
$2.42M Buy
682,092
+378,858
+125% +$1.37M ﹤0.01% 4315
2025
Q2
$828K Sell
303,234
-250,171
-45% -$516K ﹤0.01% 4831
2025
Q1
$930K Sell
553,405
-451,246
-45% -$1.26M ﹤0.01% 4735
2024
Q4
$1.64M Buy
1,004,651
+154,653
+18% +$461K ﹤0.01% 4459
2024
Q3
$3.54M Buy
849,998
+32,662
+4% +$172K ﹤0.01% 3663
2024
Q2
$4.46M Sell
817,336
-35,440
-4% -$282K ﹤0.01% 3254
2024
Q1
$8.53M Buy
852,776
+22,484
+3% +$168K ﹤0.01% 2621
2023
Q4
$3.39M Buy
830,292
+215,650
+35% +$794K ﹤0.01% 3494
2023
Q3
$2.38M Sell
614,642
-244,607
-28% -$1.31M ﹤0.01% 3635
2023
Q2
$5.12M Sell
859,249
-116,845
-12% -$673K ﹤0.01% 3091
2023
Q1
$3.19M Sell
976,094
-888,404
-48% -$3.55M ﹤0.01% 3474
2022
Q4
$7.36M Buy
1,864,498
+453,630
+32% +$2.22M ﹤0.01% 2843
2022
Q3
$8.47M Buy
1,410,868
+559,841
+66% +$4.04M ﹤0.01% 2653
2022
Q2
$5.47M Buy
851,027
+255,738
+43% +$1.63M ﹤0.01% 3053
2022
Q1
$4.92M Buy
595,289
+205,796
+53% +$1.66M ﹤0.01% 3372
2021
Q4
$6.03M Buy
389,493
+116,168
+43% +$2.24M ﹤0.01% 3228
2021
Q3
$6.16M Sell
273,325
-94,663
-26% -$1.99M ﹤0.01% 3180
2021
Q2
$7.24M Buy
367,988
+211,202
+135% +$4.79M ﹤0.01% 3012
2021
Q1
$5.25M Buy
+156,786
New +$5.11M ﹤0.01% 3095

Other funds holding SANA